Since loss of BRCA1 leads to the hyperactivation of mTORC2, it may be possible that breast cancer cells lacking BRCA1 could be dependent upon mTORC2 signaling and more sensitive to its inhibition. This evidence concerns the gene BRCA1 and breast cancer.